Navigation Links
Periodic in Biological Technology

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing

... as well as other factors expressed from time to time in the Company's periodic filings with the SEC. As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

Zimmer Launches New Medical Education and BioSkills Training Program

... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...

Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing

... as well as other factors expressed from time to time in the Company's periodic filings with the SEC. As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

ArborGen and Senesco Announce Wood Quality Results

... AMEX, as well as other factors expressed from time to time in Senesco's periodic filings with the Securities and Exchange Commission (the " SEC" ). As a result, this press release should be read in conjunction with Senesco's periodic filings with the SEC. The forward-looking statements contained herein are ...

Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors

... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the " SEC" ). As a ... this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy

... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

Poniard Pharmaceuticals Files Shelf Registration

... is intended to provide the Company with flexibility to facilitate the periodic sale of its securities, subject to market conditions and the Company's ... and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including ...

Results From Phase 3 CAPACITY Program of Pirfenidone in IPF and Study of Predictors of Mortality in IPF to be Presented at ATS

... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results

... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

United Therapeutics Reports First Quarter 2009 Financial Results

... subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could ... statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, ...

InterMune Reports First Quarter 2009 Financial Results and Business Highlights

... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients

... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting

... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

INFORM-1 Interim Results Accepted for Late-Breaker Presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)

... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Palatin Technologies' Listing Compliance Plan Accepted by NYSE Alternext US

... on the Exchange during the plan period through June 23, 2010, subject to periodic review by the Exchange to determine if Palatin is making progress ... its intellectual property, and other factors discussed in the Palatin's periodic filings with the Securities and Exchange Commission. Palatin is not ...

InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

InterMune Announces Issuance of U.S. Patent for ITMN-191

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results

... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the " SEC" ). As a ... this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC. Completion of the offering is subject to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Palatin Technologies Receives Notification Letter from NYSE Alternext US

... its listing during the plan period through July 23, 2010, subject to periodic review by the Exchange to determine if it is making progress consistent ... its intellectual property, and other factors discussed in the Palatin's periodic filings with the Securities and Exchange Commission. Palatin is not ...

Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring

... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

Surface plasmon resonances of metal nanoparticles in array can have narrower spectral widths

... that the surface plasmon resonances of metal nanoparticles in a periodic array can have considerably narrower spectral widths than those of ... Further, as the optical fields are significantly more intense in a periodic array, the method could improve the sensitivity of detecting molecules at ...

InterMune Reports Third Quarter 2008 Financial Results and Business Highlights

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

United Therapeutics Reports Third Quarter 2008 Financial Results

... subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could ... statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, ...

InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology

... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...

InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Watson Pharmaceuticals Reports Second Quarter 2008 Results

... mix between the Company's Brand, Generic and Distribution business units; periodic dependence on a small number of products for a material source of net ... products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but ...

InterMune Reports Second Quarter 2008 Financial Results and Business Highlights

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

United Therapeutics Reports Second Quarter 2008 Financial Results

... subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could ... statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, ...

Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct

... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...

Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook

... mix between the Company's Brand, Generic and Distribution business units; periodic dependence on a small number of products for a material source of net ... products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but ...

Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing

... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...

Zimmer Holdings Announces Support for Elimination of Super-Majority Voting Requirements

... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...

Two-faced miniatures

... micrometers wide). The bottom portion of the device is a phase mask with a periodic surface structure. This arrangement is irradiated through a transparency ... with sides of 60 m. Once the parallel light rays pass through the strictly periodic surface structure of the phase mask, the result is a complex ...

Zimmer Announces Settlement of Federal Investigation

... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...

Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products

... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...
Other Contents
(Date:5/17/2013)... An international team of scientists using a ... movement inside a living frog embryo in greater detail ... to advance biological research and the search for new ... the Karlsruher Institut fr Technologie in Germany, in collaboration ... of Energy,s Argonne National Laboratory, released the most precise ...
(Date:5/16/2013)... MARC (Maximizing Access to Research Careers) Program has ... Society (ENDO) 95th Annual Meeting in San Francisco, ... meant to promote the entry of students, postdoctorates ... of the basic science community and to encourage ... 2013 Annual Meeting. , Awards are given to ...
(Date:5/16/2013)... African-American adults living closer to a fast food restaurant ... who lived further away from fast food, according to ... Center, and this association was particularly strong among those ... published online in the American Journal of Public ... to a fast food restaurant, and among lower-income African-Americans, ...
Breaking Biology News(10 mins):New X-ray method shows how frog embryos could help thwart disease 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3
(Date:5/19/2013)... Chicago, IL (PRWEB) May 19, 2013 In ... Surge, LLC, E-dentist.com has announced the launch of an SEO ... help dentists get high rankings in Google. , http://www.e-dentists.com/ ... do not pay for the service until they see results. ... sites. The lead generation websites run by JD Media Surge, ...
(Date:5/19/2013)... 19, 2013 Grinding your teeth at ... sleep, or annoying your spouse. At the same time, ... Central (“Snoring and Teeth Grinding Could Be a Sign ... grinding can be hard to prevent. Apparently, Obstructive Sleep ... one of its symptoms is a habit of teeth ...
(Date:5/19/2013)... The report “Feed Additives Market by Types, Livestock & ... published by MarketsandMarkets, defines and segments the global animal ... global volume and revenue for the animal feed additives. ... the global market with analysis of trends, opportunities, burning ... and revenue is forecasted on the basis of major ...
(Date:5/19/2013)... Farming methods have changed many times since man ... ago. Most recently, the Green Revolution has transformed farming ... seeds and by applying chemical fertilizers and pesticides. But ... due to the adverse environmental and health effects of ... interest in organic, sustainable farming practices and techniques. Enter ...
(Date:5/19/2013)... Los Angeles (PRWEB) May 19, 2013 Yeast ... infections can appear in sensitive areas of the human body. ... by Yeastrol. This new formula provides a unique method of ... This new spray solution is now provided to men and ... Yeast is naturally absorbed in the body through food and ...
Breaking Medicine News(10 mins):Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2
Other TagsOther Tags